FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1600517462> ?p ?o ?g. }

• W1600517462 endingPage "2911" @default.
• W1600517462 startingPage "2904" @default.
• W1600517462 abstract "Abstract Introduction The prevalence of erectile dysfunction (ED) is increased in men with metabolic syndrome compared with the general population. Aim The aim of this study was to evaluate the efficacy and safety of vardenafil vs. placebo in men who had ED and metabolic syndrome. Methods This was a 12-week, double-blind, randomized, multicenter, parallel-group, placebo-controlled prospective study in men with ED and metabolic syndrome (assessed by the International Diabetes Federation criteria). Vardenafil was administered at a starting dose of 10 mg, which could be titrated to 5 mg or 20 mg after 4 weeks, depending on efficacy and tolerability. Main Outcome Measures Primary efficacy measures were the erectile function domain of the International Index of Erectile Function (IIEF-EF) and Sexual Encounter Profile (SEP) diary questions 2/3. Secondary efficacy measures included SEP1, a diary question assessing ejaculation, the percentage of men achieving “return-to-normal” erectile function, and the percentage of men who titrated to a different dose. Adverse events (AEs) were recorded throughout the study. Results The intent-to-treat population included 145 men (vardenafil, N = 75; placebo, N = 70). Baseline least squares IIEF-EF domain scores were low (vardenafil: 12.0; placebo: 12.7), indicative of moderate-to-severe ED. Vardenafil was statistically significantly superior to placebo for all primary efficacy measures (P &lt; 0.0001) and showed nominally statistically significant superiority compared with placebo for SEP1/ejaculation success rates (P = 0.0003 and P &lt; 0.0001, respectively) and the percentage of subjects reporting “return-to-normal” erectile function (P = 0.0004). Treatment-emergent AEs were mild-to-moderate in severity and consistent with the known AE profile of phosphodiesterase type 5 inhibitors. Conclusions This is the first study to assess the efficacy and safety of vardenafil, taken alone, for ED therapy in a population of men who all had metabolic syndrome. Although baseline erectile function in these patients was low, vardenafil treatment was associated with significant improvements in erectile function and rates of successful intercourse, and was well tolerated." @default.
• W1600517462 created "2016-06-24" @default.
• W1600517462 creator A5013713754 @default.
• W1600517462 creator A5052878309 @default.
• W1600517462 creator A5059611977 @default.
• W1600517462 creator A5060991124 @default.
• W1600517462 creator A5065774147 @default.
• W1600517462 creator A5085073457 @default.
• W1600517462 date "2011-10-01" @default.
• W1600517462 modified "2023-09-27" @default.
• W1600517462 title "Efficacy and Safety of Vardenafil for the Treatment of Erectile Dysfunction in Men with Metabolic Syndrome: Results of a Randomized, Placebo-Controlled Trial" @default.
• W1600517462 cites W1513765308 @default.
• W1600517462 cites W1577498128 @default.
• W1600517462 cites W1721029593 @default.
• W1600517462 cites W1972896927 @default.
• W1600517462 cites W1975351242 @default.
• W1600517462 cites W2004135674 @default.
• W1600517462 cites W2014865281 @default.
• W1600517462 cites W2015126772 @default.
• W1600517462 cites W2035425530 @default.
• W1600517462 cites W2035776427 @default.
• W1600517462 cites W2039531580 @default.
• W1600517462 cites W2041626476 @default.
• W1600517462 cites W2045650855 @default.
• W1600517462 cites W2062498555 @default.
• W1600517462 cites W2093237077 @default.
• W1600517462 cites W2110109612 @default.
• W1600517462 cites W2122948438 @default.
• W1600517462 cites W2150494864 @default.
• W1600517462 cites W2156867396 @default.
• W1600517462 cites W2162077159 @default.
• W1600517462 cites W2162274429 @default.
• W1600517462 doi "https://doi.org/10.1111/j.1743-6109.2011.02383.x" @default.
• W1600517462 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21771281" @default.
• W1600517462 hasPublicationYear "2011" @default.
• W1600517462 type Work @default.
• W1600517462 sameAs 1600517462 @default.
• W1600517462 citedByCount "10" @default.
• W1600517462 countsByYear W16005174622012 @default.
• W1600517462 countsByYear W16005174622013 @default.
• W1600517462 countsByYear W16005174622014 @default.
• W1600517462 countsByYear W16005174622015 @default.
• W1600517462 countsByYear W16005174622016 @default.
• W1600517462 countsByYear W16005174622020 @default.
• W1600517462 crossrefType "journal-article" @default.
• W1600517462 hasAuthorship W1600517462A5013713754 @default.
• W1600517462 hasAuthorship W1600517462A5052878309 @default.
• W1600517462 hasAuthorship W1600517462A5059611977 @default.
• W1600517462 hasAuthorship W1600517462A5060991124 @default.
• W1600517462 hasAuthorship W1600517462A5065774147 @default.
• W1600517462 hasAuthorship W1600517462A5085073457 @default.
• W1600517462 hasConcept C126322002 @default.
• W1600517462 hasConcept C142724271 @default.
• W1600517462 hasConcept C197934379 @default.
• W1600517462 hasConcept C204787440 @default.
• W1600517462 hasConcept C27081682 @default.
• W1600517462 hasConcept C2777812360 @default.
• W1600517462 hasConcept C2778375690 @default.
• W1600517462 hasConcept C2778822586 @default.
• W1600517462 hasConcept C2779929075 @default.
• W1600517462 hasConcept C2780816001 @default.
• W1600517462 hasConcept C2908647359 @default.
• W1600517462 hasConcept C71924100 @default.
• W1600517462 hasConcept C99454951 @default.
• W1600517462 hasConceptScore W1600517462C126322002 @default.
• W1600517462 hasConceptScore W1600517462C142724271 @default.
• W1600517462 hasConceptScore W1600517462C197934379 @default.
• W1600517462 hasConceptScore W1600517462C204787440 @default.
• W1600517462 hasConceptScore W1600517462C27081682 @default.
• W1600517462 hasConceptScore W1600517462C2777812360 @default.
• W1600517462 hasConceptScore W1600517462C2778375690 @default.
• W1600517462 hasConceptScore W1600517462C2778822586 @default.
• W1600517462 hasConceptScore W1600517462C2779929075 @default.
• W1600517462 hasConceptScore W1600517462C2780816001 @default.
• W1600517462 hasConceptScore W1600517462C2908647359 @default.
• W1600517462 hasConceptScore W1600517462C71924100 @default.
• W1600517462 hasConceptScore W1600517462C99454951 @default.
• W1600517462 hasIssue "10" @default.
• W1600517462 hasLocation W16005174621 @default.
• W1600517462 hasLocation W16005174622 @default.
• W1600517462 hasOpenAccess W1600517462 @default.
• W1600517462 hasPrimaryLocation W16005174621 @default.
• W1600517462 hasRelatedWork W1600517462 @default.
• W1600517462 hasRelatedWork W1996790738 @default.
• W1600517462 hasRelatedWork W2039249451 @default.
• W1600517462 hasRelatedWork W2041626476 @default.
• W1600517462 hasRelatedWork W2068913937 @default.
• W1600517462 hasRelatedWork W2072069294 @default.
• W1600517462 hasRelatedWork W2129071938 @default.
• W1600517462 hasRelatedWork W2150494864 @default.
• W1600517462 hasRelatedWork W2183735175 @default.
• W1600517462 hasRelatedWork W2327524689 @default.
• W1600517462 hasVolume "8" @default.
• W1600517462 isParatext "false" @default.
• W1600517462 isRetracted "false" @default.
• W1600517462 magId "1600517462" @default.
• W1600517462 workType "article" @default.